Next Article in Journal
Current Role of Lipoprotein Apheresis in the Treatment of High-Risk Patients
Next Article in Special Issue
Defective Vagal Innervation in Murine Tbx1 Mutant Hearts
Previous Article in Journal
The Development of Compartmentation of cAMP Signaling in Cardiomyocytes: The Role of T-Tubules and Caveolae Microdomains
Previous Article in Special Issue
Enlightening the Association between Bicuspid Aortic Valve and Aortopathy
Open AccessFeature PaperReview

The Role of scaRNAs in Adjusting Alternative mRNA Splicing in Heart Development

1
College of Biosciences, Kansas City University, Kansas City, MO 64106, USA
2
Ward Family Heart Center, Children’s Mercy Hospital, University of Missouri-Kansas City School of Medicine, Kansas City, MO 64108, USA
3
Frontier Science Research Center, University of Miyazaki, Miyazaki 889-1692, Japan
*
Author to whom correspondence should be addressed.
These two authors contributed equally to this manuscript.
J. Cardiovasc. Dev. Dis. 2018, 5(2), 26; https://doi.org/10.3390/jcdd5020026
Received: 30 March 2018 / Revised: 27 April 2018 / Accepted: 3 May 2018 / Published: 8 May 2018
(This article belongs to the Special Issue Genetics of Congenital Heart Disease)
Congenital heart disease (CHD) is a leading cause of death in children <1 year of age. Despite intense effort in the last 10 years, most CHDs (~70%) still have an unknown etiology. Conotruncal based defects, such as Tetralogy of Fallot (TOF), a common complex of devastating heart defects, typically requires surgical intervention in the first year of life. We reported that the noncoding transcriptome in myocardial tissue from children with TOF is characterized by significant variation in levels of expression of noncoding RNAs, and more specifically, a significant reduction in 12 small cajal body-associated RNAs (scaRNAs) in the right ventricle. scaRNAs are essential for the biochemical modification and maturation of small nuclear RNAs (spliceosomal RNAs), which in turn are critical components of the spliceosome. This is particularly important because we also documented that splicing of mRNAs that are critical for heart development was dysregulated in the heart tissue of infants with TOF. Furthermore, we went on to show, using the zebrafish model, that altering the expression of these same scaRNAs led to faulty mRNA processing and heart defects in the developing embryo. This review will examine how scaRNAs may influence spliceosome fidelity in exon retention during heart development and thus contribute to regulation of heart development. View Full-Text
Keywords: alternative mRNA splicing; congenital heart defects; scaRNAs; small cajal body-associated RNAs; tetralogy of Fallot alternative mRNA splicing; congenital heart defects; scaRNAs; small cajal body-associated RNAs; tetralogy of Fallot
Show Figures

Graphical abstract

MDPI and ACS Style

Nagasawa, C.; Ogren, A.; Kibiryeva, N.; Marshall, J.; O’Brien, J.E.; Kenmochi, N.; Bittel, D.C. The Role of scaRNAs in Adjusting Alternative mRNA Splicing in Heart Development. J. Cardiovasc. Dev. Dis. 2018, 5, 26.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop